Great news from Business Week

Here's a really interesting article from Business Week about a drug in development for Alzheimer's. It's based on a century old malaria drug and is a new approach that doesn't focus on amyloid, instead looking at a protein called Tau (which shouldn't be confused with Tao.) The research is very encouraging. Yay!

TauRx Therapeutics, a private company based in Singapore, just reported that its drug Rember reduced mental decline by 81% over 12 months in a small phase II trial. The results have yet to be published and need to be confirmed by a larger trial. But so far, Rember has outperformed high-profile Alzheimer's drugs made by far larger companies. And it works by going after a completely different target.